Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessmulti-pass transmembrane protein insertion into ER membrane

NOMO1 NOMO2 NOMO3

9.09e-0691003GO:0160063
GeneOntologyCellularComponentmulti-pass translocon complex

NOMO1 NOMO2 NOMO3

9.27e-0691023GO:0160064
GeneOntologyCellularComponentER membrane insertion complex

NOMO1 NOMO2 NOMO3

3.95e-05141023GO:0072379
GeneOntologyCellularComponentcostamere

FLNC AHNAK AHNAK2

1.62e-04221023GO:0043034
DomainDUF2012

NOMO1 NOMO2 NOMO3

5.41e-074973PF09430
DomainDUF2012

NOMO1 NOMO2 NOMO3

5.41e-074973IPR019008
DomainCarb-bd-like_fold

NOMO1 NOMO2 NOMO3

7.46e-068973IPR013784
DomainCarboxyPept_regulatory_dom

NOMO1 NOMO2 NOMO3

3.74e-0513973IPR014766
Domain-

NOMO1 NOMO2 NOMO3

3.74e-05139732.60.40.1120
DomainLamG

FAT4 COL15A1 NRXN3 CSPG4

7.91e-0544974SM00282
DomainCarboxyPept-like_regulatory

NOMO1 NOMO2 NOMO3

8.76e-0517973IPR008969
DomainZF_CR

DNAJA2 DNAJA1

1.59e-044972PS51188
DomainDnaJ

DNAJA2 DNAJA1

1.59e-044972IPR012724
DomainDnaJ_CXXCXGXG

DNAJA2 DNAJA1

1.59e-044972PF00684
Domain-

DNAJA2 DNAJA1

1.59e-0449722.10.230.10
DomainLaminin_G

FAT4 COL15A1 NRXN3 CSPG4

2.34e-0458974IPR001791
DomainHSP_DnaJ_Cys-rich_dom

DNAJA2 DNAJA1

2.64e-045972IPR001305
DomainDnaJ_C

DNAJA2 DNAJA1

9.39e-049972IPR002939
DomainDnaJ_C

DNAJA2 DNAJA1

9.39e-049972PF01556
DomainHSP40/DnaJ_pept-bd

DNAJA2 DNAJA1

9.39e-049972IPR008971
DomainConA-like_dom

FAT4 COL15A1 ZAN NRXN3 CSPG4 SPRYD4

9.88e-04219976IPR013320
DomainLAM_G_DOMAIN

FAT4 NRXN3 CSPG4

1.00e-0338973PS50025
DomainLaminin_G_2

FAT4 NRXN3 CSPG4

1.17e-0340973PF02210
DomainPA

RNF149 EDEM3

4.31e-0319972PF02225
DomainPA_domain

RNF149 EDEM3

4.31e-0319972IPR003137
PathwayBIOCARTA_EFP_PATHWAY

CDK3 CDK4 CDK6

3.38e-0513713MM1537
PathwayBIOCARTA_EFP_PATHWAY

CDK3 CDK4 CDK6

6.54e-0516713M22011
Pubmed

A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.

DNAJA2 NUMA1 ABCE1 MKI67 HADHA DNAJA1 GCN1 CDK3 CDK4 CDK6

4.02e-121251021021654808
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

FLNC DNAJA2 RSF1 NUMA1 AAK1 GTF3C3 ASAP1 SLC25A12 MYH14 ABCE1 FUBP1 RPTOR AHNAK POP1 MKI67 HADHA ARHGEF2 DNAJA1 GCN1 MVP AHNAK2 EXOC4

4.91e-1113531022229467282
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

FLNC USP9X RSF1 INTS1 NUMA1 GTF3C3 IARS2 MYH14 ABCE1 AHNAK POP1 MKI67 HADHA DNAJA1 GCN1 MVP

8.47e-116531021622586326
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

EDC3 USP9X RSF1 NUMA1 AAK1 ZYX FUBP1 RPTOR MKI67 ZNF579 ARHGEF2 CDK3 EXOC4

3.01e-095031021316964243
Pubmed

The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.

EDC3 TRIO ZYX ABCE1 FUBP1 AHNAK MKI67 HADHA ARHGEF2 AHNAK2

1.95e-082981021030737378
Pubmed

Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.

NOMO1 NOMO2 NOMO3

2.45e-083102336011023
Pubmed

Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.

NOMO1 NOMO2 NOMO3

2.45e-083102325576386
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

HSP90AB4P TRIO DNAJA2 NUMA1 RNF149 ZYX EDEM3 MAP1S NOMO2 FUBP1 AHNAK POP1 MKI67 CERCAM HADHA DNAJA1 NBR1 CDK6

4.04e-0812971021833545068
Pubmed

Defining the membrane proteome of NK cells.

EDC3 USP9X INTS1 RNF149 FYCO1 NOMO1 MYH14 ABCE1 LPCAT3 AHNAK MKI67 DNAJA1 GCN1 MVP NBR1 EXOC4 NCKAP1L

5.11e-0811681021719946888
Pubmed

Charting the molecular network of the drug target Bcr-Abl.

USP9X DNAJA2 AAK1 USP9Y ASAP1 MYH14 AHNAK POP1 DNAJA1

9.64e-08266102919380743
Pubmed

Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.

NOMO1 NOMO2 NOMO3

9.78e-084102331833031
Pubmed

A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.

NOMO1 NOMO2 NOMO3

9.78e-08410239267806
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

FLNC DNAJA2 NUMA1 WDR81 FYCO1 IARS2 MYH14 ABCE1 AHNAK POP1 MYOCD HADHA GCN1 AHNAK2

1.06e-078071021430575818
Pubmed

C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.

USP9X DNAJA2 INTS1 GTF3C3 ZWINT NOMO1 IARS2 SLC25A12 MAP1S NOMO2 ABCE1 RPTOR HADHA DNAJA1 GCN1 NOMO3 CDK4

1.45e-0712571021737317656
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

HSP90AB4P TRIO USP9X DNAJA2 NUMA1 GTF3C3 NOMO1 IARS2 MYH14 ABCE1 FUBP1 RPTOR MKI67 HADHA DNAJA1 GCN1 NBR1 CDK4

1.64e-0714251021830948266
Pubmed

A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.

TRIO DNAJA2 NUMA1 ZYX AHNAK MKI67 HADHA DNAJA1 GCN1

1.68e-07284102929459677
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

FLNC EDC3 DNAJA2 AAK1 ZYX MYH14 AHNAK MKI67 HADHA DNAJA1 GCN1 AHNAK2 EXOC4

2.12e-077241021336232890
Pubmed

Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.

DNAJA2 HEPH NOMO1 EDEM3 SLC25A12 NOMO2 ABCE1 CERCAM ARHGEF2 DNAJA1 GCN1 NOMO3

2.58e-076131021222268729
Pubmed

mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.

FLNC IARS2 AHNAK HADHA ARHGEF2 GCN1 MVP AHNAK2 EXOC4

3.70e-07312102937120454
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

FLNC USP9X NUMA1 GTF3C3 ANKRD13A IARS2 HADHA ARHGEF2 GCN1

3.80e-07313102938270169
Pubmed

Ablation of cdk4 and cdk6 affects proliferation of basal progenitor cells in the developing dorsal and ventral forebrain.

MKI67 CDK4 CDK6

4.87e-076102329570951
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

USP9X DNAJA2 GTF3C3 ANKRD13A SLC25A12 RPTOR HADHA ARHGEF2 DNAJA1 GCN1 NBR1 NOMO3 CDK4 EXOC4

6.78e-079421021431073040
Pubmed

Interaction between Cdc37 and Cdk4 in human cells.

CDK3 CDK4 CDK6

8.50e-07710239150368
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

TRIO USP9X DNAJA2 KSR2 NUMA1 AAK1 WDR81 FYCO1 TMEM132B SPTBN4 P2RX7 RPTOR ARHGEF2 DNAJA1

8.80e-079631021428671696
Pubmed

KAP1 facilitates reinstatement of heterochromatin after DNA replication.

DNAJA2 NUMA1 IARS2 SLC25A12 MAP1S ABCE1 HADHA DNAJA1 GCN1 CDK4 EXOC4 CDK6

1.11e-067041021229955894
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

EDC3 USP9X NUMA1 AAK1 FRS2 ATE1 ABCE1 AHNAK HADHA DNAJA1 GCN1 EXOC4

1.17e-067081021239231216
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

INTS1 ITPK1 MYO15B FUBP1 AHNAK ARHGEF2 DNAJA1 GCN1 MVP CDK3 EXOC4

1.18e-065821021120467437
Pubmed

Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.

FLNC USP9X DNAJA2 RSF1 MYH14 ABCE1 FUBP1 AHNAK MKI67 HADHA DNAJA1 GCN1 MVP

1.18e-068441021325963833
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

TCAF2 FLNC NUMA1 AAK1 FUBP1 AHNAK ZNF579 MVP AHNAK2

1.21e-06360102933111431
Pubmed

A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways.

EDC3 USP9X DNAJA2 KSR2 IARS2 FGFR3 DNAJA1 CDK4 CDK6

1.30e-06363102925036637
Pubmed

A family of human cdc2-related protein kinases.

CDK3 CDK4 CDK6

1.36e-06810231639063
Pubmed

Cdk5 levels oscillate during the neuronal cell cycle: Cdh1 ubiquitination triggers proteosome-dependent degradation during S-phase.

CDK3 CDK4 CDK6

1.36e-068102322654103
Pubmed

Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.

NOMO1 NOMO2 NOMO3

1.36e-068102315257293
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

EDC3 DNAJA2 NUMA1 GTF3C3 ZWINT FANCE EDEM3 MAP1S AHNAK POP1 MKI67 HADHA DNAJA1 GCN1 EXOC4

1.41e-0611551021520360068
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

EDC3 TRIO DNAJA2 RNF149 SPG11 ZWINT EDEM3 IARS2 NOMO2 ARHGEF2 DNAJA1 NBR1

1.68e-067331021234672954
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

CACNA1F FAT4 EDC3 INTS1 FRS2 TMEM132B MYO15B ABCE1 AHNAK POP1 HADHA DNAJA1

1.75e-067361021229676528
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

FLNC DNAJA2 NUMA1 MYH14 RPTOR AHNAK MKI67 DNAJA1 GCN1 MVP

2.02e-064941021026831064
Pubmed

Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death.

CDK3 CDK4 CDK6

2.03e-06910239438340
Pubmed

Substrate-driven assembly of a translocon for multipass membrane proteins.

NOMO1 NOMO2 NOMO3

2.03e-069102336261522
Pubmed

Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.

EDC3 USP9X INTS1 NUMA1 AAK1 ZYX MAP1S AHNAK GCN1 CDK6

2.18e-064981021036634849
Pubmed

Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.

FLNC USP9X DNAJA2 AAK1 ZYX ASAP1 ANKRD13A REXO2 IARS2 ABCE1 AHNAK HADHA DNAJA1 GCN1 MVP AHNAK2

2.33e-0613671021632687490
Pubmed

Oct4 links multiple epigenetic pathways to the pluripotency network.

DNAJA2 NUMA1 AHNAK HADHA DNAJA1 GCN1 CDK3

2.40e-06203102722083510
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

DNAJA2 INTS1 NUMA1 GTF3C3 AHNAK POP1 HADHA DNAJA1 EXOC4

2.54e-06394102927248496
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

TRIO INTS1 AAK1 ZYX NOMO1 MAP1S NOMO2 ABCE1 FGFR3 ARHGEF2 NOMO3 CDK3 CDK6

2.71e-069101021336736316
Pubmed

Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.

FLNC DNAJA2 NUMA1 ZYX FUBP1 CRLF3 AHNAK MKI67 DNAJA1

2.82e-06399102935987950
Pubmed

BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.

AAK1 ZYX IARS2 AHNAK GCN1 AHNAK2 CDK6

3.62e-06216102731519766
Pubmed

PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation.

USP9X DNAJA2 GTF3C3 POP1 MKI67 HADHA DNAJA1

3.73e-06217102731685992
Pubmed

An ER translocon for multi-pass membrane protein biogenesis.

NOMO1 NOMO2 NOMO3

3.97e-0611102332820719
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

FLNC TRIO KSR2 INTS1 FYCO1 LPIN3 MAP1S RPTOR AHNAK CSPG4 ZNF579 ARHGEF2 GCN1 AHNAK2

4.35e-0611051021435748872
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

FLNC NLRP7 RSF1 NUMA1 SPG11 SPTBN4 NRXN3 SLC25A12 MYH14 FUBP1 AHNAK CSPG4 HADHA ARHGEF2 DNAJA1 DOP1A

4.61e-0614421021635575683
Pubmed

Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.

USP9X USP9Y MAP1S ABCE1 HADHA GCN1 CDK3 CDK4 CDK6

5.35e-06432102923455922
Pubmed

Network organization of the human autophagy system.

FLNC FYCO1 GTF3C3 ZWINT MAP1S RPTOR HADHA GCN1 NBR1

5.87e-06437102920562859
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

TRIO USP9X DNAJA2 AAK1 ATE1 ASAP1 ZWINT MAP1S ACSBG1 ABCE1 RPTOR HADHA DNAJA1 GCN1

6.14e-0611391021436417873
Pubmed

The Catalytically Inactive Mutation of the Ubiquitin-Conjugating Enzyme CDC34 Affects its Stability and Cell Proliferation.

DNAJA2 GTF3C3 SLC25A12 HADHA DNAJA1 GCN1 EXOC4

6.65e-06237102729564676
Pubmed

WDFY4 is required for cross-presentation in response to viral and tumor antigens.

NOMO1 NOMO2 AHNAK DNAJA1 NOMO3 AHNAK2

6.98e-06156102630409884
Pubmed

LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.

FLNC USP9X DNAJA2 NOMO1 NOMO2 GCN1 NOMO3 NCKAP1L

8.26e-06344102830333137
Pubmed

Defining the transcriptional and biological response to CDK4/6 inhibition in relation to ER+/HER2- breast cancer.

CDK4 CDK6

8.52e-062102227564114
Pubmed

A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas.

CDK4 CDK6

8.52e-062102227542767
Pubmed

To Cycle or Fight-CDK4/6 Inhibitors at the Crossroads of Anticancer Immunity.

CDK4 CDK6

8.52e-062102230224338
Pubmed

Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure.

FLNC TRIO

8.52e-062102216914736
Pubmed

Cdk4 and Cdk6 Couple the Cell-Cycle Machinery to Cell Growth via mTORC1.

CDK4 CDK6

8.52e-062102232294430
Pubmed

Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6.

CDK4 CDK6

8.52e-062102226988987
Pubmed

RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypes.

CDK4 CDK6

8.52e-062102234932500
Pubmed

Beyond the Cell Cycle: Enhancing the Immune Surveillance of Tumors Via CDK4/6 Inhibition.

CDK4 CDK6

8.52e-062102229934327
Pubmed

Diagnostic and Prognostic Implications of FGFR3high/Ki67high Papillary Bladder Cancers.

MKI67 FGFR3

8.52e-062102230154342
Pubmed

CDK4/6 Inhibition Sensitizes Intracranial Tumors to PD-1 Blockade in Preclinical Models of Brain Metastasis.

CDK4 CDK6

8.52e-062102237611074
Pubmed

Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner.

CDK4 CDK6

8.52e-062102228453226
Pubmed

Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma.

CDK4 CDK6

8.52e-062102230899002
Pubmed

Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome.

USP9X USP9Y

8.52e-062102212895410
Pubmed

CDK4/6 are necessary for UCP1-mediated thermogenesis of white adipose tissue.

CDK4 CDK6

8.52e-062102237011871
Pubmed

Deciphering the Immunomodulatory Role of Cyclin-Dependent Kinase 4/6 Inhibitors in the Tumor Microenvironment.

CDK4 CDK6

8.52e-062102236768557
Pubmed

The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells.

AHNAK AHNAK2

8.52e-062102215007166
Pubmed

The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer.

CDK4 CDK6

8.52e-062102235095879
Pubmed

Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers.

CDK4 CDK6

8.52e-062102226857361
Pubmed

Expression of cyclin-dependent kinase 6, but not cyclin-dependent kinase 4, alters morphology of cultured mouse astrocytes.

CDK4 CDK6

8.52e-062102212861051
Pubmed

Inhibition of CDK4/6 kinases causes production of aneuploid oocytes by inactivating the spindle assembly checkpoint and accelerating first meiotic progression.

CDK4 CDK6

8.52e-062102233865884
Pubmed

The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2.

USP9X USP9Y

8.52e-06210228922996
Pubmed

Altered G1 signaling order and commitment point in cells proliferating without CDK4/6 activity.

CDK4 CDK6

8.52e-062102233082317
Pubmed

Physiologically Based Pharmacokinetic Modeling of Central Nervous System Pharmacokinetics of CDK4/6 Inhibitors to Guide Selection of Drug and Dosing Regimen for Brain Cancer Treatment.

CDK4 CDK6

8.52e-062102232799335
Pubmed

Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling.

CDK4 CDK6

8.52e-062102236907286
Pubmed

Modification of the DNA damage response by therapeutic CDK4/6 inhibition.

CDK4 CDK6

8.52e-062102222733811
Pubmed

A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence.

CDK4 CDK6

8.52e-062102227206849
Pubmed

Usp9y (ubiquitin-specific protease 9 gene on the Y) is associated with a functional promoter and encodes an intact open reading frame homologous to Usp9x that is under selective constraint.

USP9X USP9Y

8.52e-062102212925892
Pubmed

GEFH1 binds ASAP1 and regulates podosome formation.

ASAP1 ARHGEF2

8.52e-062102221352810
Pubmed

Inducible deletion of CDK4 and CDK6 - deciphering CDK4/6 inhibitor effects in the hematopoietic system.

CDK4 CDK6

8.52e-062102232855282
Pubmed

Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways.

CDK4 CDK6

8.52e-062102233372040
Pubmed

Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors.

CDK4 CDK6

8.52e-062102233409716
Pubmed

Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation.

CDK4 CDK6

8.52e-062102232255427
Pubmed

CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity.

CDK4 CDK6

8.52e-062102225744718
Pubmed

Understanding divergent trial results of adjuvant CDK4/6 inhibitors for early stage breast cancer.

CDK4 CDK6

8.52e-062102233689702
Pubmed

Hsp40 proteins phase separate to chaperone the assembly and maintenance of membraneless organelles.

DNAJA2 DNAJA1

8.52e-062102233229560
Pubmed

Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts.

CDK4 CDK6

8.52e-062102220354191
Pubmed

AHNAK1 and AHNAK2 are costameric proteins: AHNAK1 affects transverse skeletal muscle fiber stiffness.

AHNAK AHNAK2

8.52e-062102220833135
Pubmed

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial.

CDK4 CDK6

8.52e-062102231351869
Pubmed

Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions.

CDK4 CDK6

8.52e-062102220618617
Pubmed

The Role of CDK4/6 Inhibition in Breast Cancer.

CDK4 CDK6

8.52e-062102225876993
Pubmed

miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway.

CDK4 CDK6

8.52e-062102229073835
Pubmed

CDK4/6 regulate lysosome biogenesis through TFEB/TFE3.

CDK4 CDK6

8.52e-062102232662822
Pubmed

Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma.

CDK4 CDK6

8.52e-062102221593195
Pubmed

Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells.

CDK4 CDK6

8.52e-062102224848372
InteractionCCND1 interactions

DNAJA2 NUMA1 ABCE1 MKI67 HADHA DNAJA1 GCN1 CDH13 CDK3 CDK4 CDK6

1.62e-072869911int:CCND1
InteractionCBLN4 interactions

SEZ6L2 NOMO1 EDEM3 NRXN3 CSPG4 CERCAM FGFR3 NOMO3

2.11e-07127998int:CBLN4
InteractionSIRT7 interactions

FLNC USP9X RSF1 INTS1 NUMA1 GTF3C3 IARS2 MYH14 ABCE1 AHNAK POP1 MKI67 HADHA DNAJA1 GCN1 MVP

6.57e-077449916int:SIRT7
InteractionLIMK2 interactions

HSP90AB4P DNAJA2 HADHA DNAJA1 GCN1 CDK4

3.60e-0684996int:LIMK2
InteractionMCM2 interactions

FLNC USP9X DNAJA2 KSR2 RSF1 NUMA1 MYH14 ABCE1 FUBP1 AHNAK MKI67 HADHA DNAJA1 GCN1 MVP NBR1 CDK4 CDK6

4.75e-0610819918int:MCM2
InteractionTEDC2 interactions

TRIO DNAJA2 NUMA1 AHNAK MKI67 HADHA DNAJA1 GCN1

8.03e-06206998int:TEDC2
InteractionTESK2 interactions

EDC3 HSP90AB4P USP9Y LPIN3 RPTOR GCN1

8.31e-0697996int:TESK2
InteractionTOLLIP interactions

TRIO RNF149 ZYX ANKRD13A MAP1S AHNAK MKI67 HADHA MVP NBR1

1.06e-053589910int:TOLLIP
InteractionFBXO6 interactions

DNAJA2 HEPH NOMO1 EDEM3 SLC25A12 NOMO2 ABCE1 CSPG4 CERCAM FGFR3 ARHGEF2 DNAJA1 GCN1 NOMO3

1.06e-057179914int:FBXO6
InteractionKCNA3 interactions

EDC3 USP9X NUMA1 AAK1 FRS2 FYCO1 ATE1 ABCE1 RPTOR AHNAK HADHA DNAJA1 GCN1 DOP1A EXOC4

2.20e-058719915int:KCNA3
InteractionLOC254896 interactions

FAT4 EDC3 CSPG4 CERCAM

5.84e-0543994int:LOC254896
InteractionUSP51 interactions

FAT4 CDK4 AHNAK2 CDK6

5.84e-0543994int:USP51
InteractionTM2D3 interactions

NOMO1 EDEM3 CSPG4 CERCAM FGFR3

5.87e-0584995int:TM2D3
InteractionBRAF interactions

RNF149 NOMO1 SPTBN4 NOMO2 RPTOR DNAJA1 NOMO3

8.48e-05212997int:BRAF
InteractionIGF1R interactions

USP9X DNAJA2 RNF149 HADHA ARHGEF2 MPZL2 DNAJA1 GCN1 CDK3 CDK4

1.00e-044679910int:IGF1R
InteractionECT2 interactions

FLNC HSP90AB4P USP9X DNAJA2 NUMA1 USP9Y NOMO1 SPTBN4 MYH14 AHNAK MKI67 HADHA MVP AHNAK2

1.08e-048879914int:ECT2
InteractionARRDC3 interactions

USP9X NUMA1 RNF149 IARS2 FGFR3 ARHGEF2 GCN1

1.19e-04224997int:ARRDC3
InteractionPML interactions

FLNC EDC3 NUMA1 AAK1 ZYX GTF3C3 MAP1S MYH14 FUBP1 LPCAT3 AHNAK GCN1 AHNAK2 CDK6

1.83e-049339914int:PML
InteractionKIF20A interactions

FLNC DNAJA2 NUMA1 USP9Y SPTBN4 ACSBG1 MYH14 FUBP1 AHNAK POP1 MKI67 HADHA GCN1 SPRYD4 AHNAK2

1.85e-0410529915int:KIF20A
InteractionAGR2 interactions

FLNC DNAJA2 NUMA1 WDR81 FYCO1 IARS2 MYH14 ABCE1 AHNAK POP1 MYOCD HADHA GCN1 AHNAK2

1.85e-049349914int:AGR2
InteractionRNF123 interactions

CACNA1F FLNC FAT4 EDC3 INTS1 FRS2 TMEM132B MYO15B ABCE1 AHNAK POP1 HADHA DNAJA1

1.95e-048249913int:RNF123
InteractionGGH interactions

NOMO1 EDEM3 CSPG4 MKI67 CERCAM FGFR3 NOMO3

1.97e-04243997int:GGH
InteractionLMBR1L interactions

USP9X DNAJA2 GTF3C3 ANKRD13A SLC25A12 RPTOR HADHA ARHGEF2 DNAJA1 GCN1 NBR1 NOMO3 CDK4 EXOC4

2.11e-049469914int:LMBR1L
InteractionPLD3 interactions

HSP90AB4P RNF149 EDEM3 FUBP1 GCN1 NBR1 NOMO3

2.13e-04246997int:PLD3
InteractionCDC34 interactions

DNAJA2 GTF3C3 SLC25A12 HADHA DNAJA1 GCN1 SPRYD4 EXOC4

2.14e-04328998int:CDC34
InteractionDKKL1 interactions

FAT4 NOMO1 HARS2 RPTOR CERCAM

2.19e-04111995int:DKKL1
InteractionC9orf72 interactions

USP9X DNAJA2 INTS1 GTF3C3 ZWINT NOMO1 IARS2 SLC25A12 MAP1S NOMO2 ABCE1 RPTOR HADHA DNAJA1 GCN1 NOMO3 CDK4

2.21e-0413199917int:C9orf72
InteractionCHMP4B interactions

FLNC USP9X DNAJA2 NUMA1 SPTBN4 MYH14 AHNAK MKI67 HADHA GCN1 MVP AHNAK2

2.32e-047279912int:CHMP4B
InteractionHSP90AB1 interactions

HSP90AB4P DNAJA2 NUMA1 SPG11 IARS2 RPTOR AHNAK FGFR3 HADHA MVP NBR1 CDK3 CDK4 CDK6

2.46e-049609914int:HSP90AB1
InteractionCDK3 interactions

HSP90AB4P FRS2 CDK3 CDK4 CDK6

2.48e-04114995int:CDK3
InteractionBIRC3 interactions

HSP90AB4P TRIO USP9X DNAJA2 NUMA1 GTF3C3 NOMO1 IARS2 ABCE1 FUBP1 RPTOR MKI67 HADHA DNAJA1 GCN1 NBR1 CDK4

2.53e-0413349917int:BIRC3
InteractionTOP3B interactions

FLNC TRIO DNAJA2 KSR2 INTS1 FYCO1 LPIN3 MAP1S RPTOR AHNAK CSPG4 HADHA ZNF579 ARHGEF2 DNAJA1 GCN1 AHNAK2 EXOC4

2.65e-0414709918int:TOP3B
Cytoband14q31

ITPK1 NRXN3

1.71e-049101214q31
GeneFamilyCyclin dependent kinases

CDK3 CDK4 CDK6

9.44e-0526623496
CoexpressionFIRESTEIN_PROLIFERATION

TRIO AAK1 FGFR3 ARHGEF2 TSKS CDK3 CDK6

3.51e-061661007M5354
CoexpressionGSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN

ZNF232 ANKRD13A PRM3 LPCAT3 DNAJA1 GCN1 MVP

9.45e-061931007M9717
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KSR2 AAK1 ITPK1 GREB1L ANKRD13A MYH14 MPZL2

3.04e-0719410174579b4a44f7c731553a284843c296866027d7c0e
ToppCellPCW_13-14-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

COL15A1 LGI4 TMEM132B NRXN3 ACSBG1 FRMD3

1.52e-0615610168353f98e7d393d4299ed1da8f66cfbc7176df1b5
ToppCellfacs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRS2 SLC5A5 CSPG4 MKI67 MYOCD SPRYD4

2.97e-061751016d8e385320f554d974538b7cdc4f8e4767f1455f2
ToppCellfacs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRS2 SLC5A5 CSPG4 MKI67 MYOCD SPRYD4

2.97e-061751016cf15465855602ba135752c18755e3e058dbd42ec
ToppCellPCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

COL15A1 LGI4 TMEM132B NRXN3 ACSBG1 FRMD3

3.17e-061771016621dd82f1393c961d4dd7a615aa52c9df9e36336
ToppCellwk_08-11-Epithelial-PNS-Proliferating_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

COL15A1 LGI4 TMEM132B ITIH5 NRXN3 FRMD3

3.38e-061791016ab23fee9adab1e63d5b5cd9faba6b9a92beef425
ToppCellP28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FLNC LGI4 ITPK1 ACSBG1 CSPG4 MKI67

3.49e-0618010161e819c5c87704ec6535dfeaae56561895e239d07
ToppCellPericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

FLNC COL15A1 LGI4 CSPG4 MYOCD CDH13

3.72e-06182101646c213597445b1f4f09dc367f27702d24b201daf
ToppCellwk_15-18-Epithelial-PNS-intermediate_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

COL15A1 LGI4 ITIH5 NRXN3 CDH13 FRMD3

3.84e-061831016d874aa9a856f79626c8a8371f6196a77b7d662ee
ToppCell5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNC ITIH5 NRXN3 CSPG4 MYOCD AHNAK2

3.84e-06183101661a73de857f4ae02dcba3af348f436f602b28ff2
ToppCellwk_08-11-Epithelial-PNS-intermediate_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

COL15A1 LGI4 TMEM132B ITIH5 ITPK1 NRXN3

4.48e-0618810163f3a744b2615bf72f6119f26087099110c0d21fc
ToppCellPericytes|World / lung cells shred on cell class, cell subclass, sample id

FLNC COL15A1 LGI4 CSPG4 MYOCD CDH13

5.06e-061921016057ad22b878c0c5fb59ed1412ca13db945c57a5a
ToppCell356C-Fibroblasts-Fibroblast-K_(Pericytes)|356C / Donor, Lineage, Cell class and subclass (all cells)

FLNC COL15A1 HEPH CSPG4 MYOCD CDH13

5.69e-061961016a5cc4f76e1a3825aaccba9a686d7da6f7e4300ff
ToppCellFibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

FLNC TRIO AHNAK CERCAM CDH13 AHNAK2

5.69e-06196101624d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell356C-Fibroblasts-Fibroblast-K_(Pericytes)-|356C / Donor, Lineage, Cell class and subclass (all cells)

FLNC COL15A1 HEPH CSPG4 MYOCD CDH13

5.69e-061961016476812fc1422aca8010d771eff11fa6081f15a2d
ToppCell5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LGI4 TMEM132B ITIH5 NRXN3 P2RX7 FRMD3

5.69e-061961016e6adcfe1a00d4910e0b92848f8a80224e0d6db12
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CACNA1F FAM83E FREM3 NRXN3 MYH14 CERCAM

6.03e-061981016b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LGI4 TMEM132B NRXN3 P2RX7 ACSBG1 FRMD3

6.21e-0619910161761669ec514fdb4175042f11b9a31fa5687fc2b
ToppCellmLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass

USP9X NUMA1 SPG11 EDEM3 AHNAK DNAJA1

6.39e-062001016e3c15e0e1c2602b0cc9ab8cc50c978d265350c94
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KSR2 FAM83E GREB1L CERCAM MPZL2

1.75e-051411015091b5b72811db5fca2314f4a79d467566920e257
ToppCellRV-16._Neuronal|World / Chamber and Cluster_Paper

LGI4 TMEM132B NRXN3 AHNAK FRMD3

2.28e-0514910153a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

EDC3 ZWINT FANCE LPCAT3 POP1

2.43e-051511015def98dc2a8226295b62de2b7f1b587e03a4f038c
ToppCellBronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FLNC HEPH CSPG4 MYOCD FRMD3

3.12e-0515910157cda111bb98f1241989e49d490bdf51a712ea589
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZAN FAM83E HARS2 TBATA EXOC4

3.72e-0516510150edd56e8d14eaeced9882dd9206ea93e8f402e8d
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZAN FAM83E HARS2 TBATA EXOC4

3.72e-051651015fa3aadfff6fb1e7f142db333c60c2cba02b17e6c
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LGI4 HEPH CSPG4 MYOCD FRMD3

3.94e-051671015e228b8373ffd4436e6b944e26d0fadf3ac289b21
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LGI4 HEPH CSPG4 MYOCD FRMD3

3.94e-0516710157cb1b11e8e24a10115e46ffbb74889e672a7a026
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LGI4 HEPH CSPG4 MYOCD FRMD3

3.94e-051671015bb53a478b5d821d6d82c15bc4ed075b67682457c
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

INTS1 MAP1S RPTOR CERCAM FGFR3

4.29e-051701015b1a16600754e0c12f7d39c9221f1b03135833f16
ToppCellP07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

LGI4 ITIH5 ITPK1 ACSBG1 FRMD3

4.54e-0517210158d6a2a0d5f63b09a5a304a77e600a647f87e9de4
ToppCellwk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

COL15A1 LGI4 TMEM132B NRXN3 FRMD3

4.66e-05173101517b1a6b0318925d5d920f2c0a791745b9587ebef
ToppCellPCW_13-14-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

COL15A1 LGI4 TMEM132B NRXN3 CDH13

4.79e-0517410150d8e737860120dcd3a6b57992c612595904d585e
ToppCellwk_20-22-Epithelial-PNS-Late_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

COL15A1 LGI4 TMEM132B NRXN3 FRMD3

5.06e-05176101581924471d8a8c5bd8eedf294c007e25b6cd3e417
ToppCellLPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

USP9Y ITIH5 NRXN3 MYH14 EXOC4

5.20e-051771015b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

TCAF2 COL15A1 SEZ6L2 HEPH CSPG4

5.48e-05179101598c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09
ToppCellRA-16._Neuronal|RA / Chamber and Cluster_Paper

LGI4 TMEM132B ITIH5 NRXN3 AHNAK

5.63e-0518010155842febfdabac61ce970254fb0ef17a628f1b8c0
ToppCell3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LGI4 TMEM132B NRXN3 ACSBG1 FRMD3

5.78e-051811015a436e7e4c36403257ea90160a58ca0d6d7c0cdfc
ToppCellSomatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEPH MYO15B ACSBG1 AHNAK FGFR3

5.78e-0518110150c3f469bed108994ed696230e3c30343f7a301d3
ToppCelldroplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LGI4 ACSBG1 MYH14 CSPG4 FRMD3

5.93e-051821015a512863304fad80acaab60a8c6107eb7c9cbac99
ToppCellPCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

LGI4 TMEM132B P2RX7 CDH13 FRMD3

5.93e-051821015f7f9be9c7ef8da9864d6aefe20043b26e1bb8697
ToppCellPericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

COL15A1 LGI4 HEPH MYOCD CDH13

6.09e-051831015d04deef7cd4e1738227a6593b84874ce0168c773
ToppCellPCW_13-14-Neuronal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

COL15A1 LGI4 TMEM132B NRXN3 FRMD3

6.25e-05184101565cf3460125e3dbc34978957bc138a449f71f7df
ToppCellLV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper

FLNC AAK1 GREB1L MYOCD CDH13

6.25e-051841015ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCellPericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id

FLNC LGI4 HEPH CSPG4 MYOCD

6.25e-0518410153d2d55d0f22874be21665ab37da710482f77fc36
ToppCellnormal-na-Lymphocytic-lymphocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

HARS2 SLC25A12 NOMO2 MKI67 DOP1A

6.25e-0518410152c286712428662bc4589dc5ac4011bf7ed403cb5
ToppCellPCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LGI4 TMEM132B P2RX7 CDH13 FRMD3

6.41e-05185101556c7a0dbf141728ac76b8c90af197719942ca67c
ToppCellSubstantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CELF6 KSR2 AAK1 SPTBN4 NRXN3

6.57e-0518610153f889083fcffe516388e9b03a5e23af2010ced33
ToppCellfacs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FLNC LGI4 ITIH5 LPIN3 CERCAM

6.74e-051871015fa8f221b4c2df61eadaa9c77e4cf45848b00330b
ToppCellPericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id

COL15A1 LGI4 GREB1L MYOCD CDH13

6.74e-05187101535f25780d113f60bf4c13749013c09612ee4ff41
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNC ZYX NRXN3 MYOCD AHNAK2

6.74e-0518710153912bbb610a4a84791e9bda92a2d57a52c31d29e
ToppCellfacs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FLNC COL15A1 LGI4 ITIH5 CERCAM

6.91e-051881015bba6b273bd47dd0e27fde914e9e6fc9d76fd5176
ToppCell5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNC ITIH5 NRXN3 CSPG4 MYOCD

6.91e-051881015879de94924de978478696fc7838e05a4d795b905
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LGI4 NRXN3 CSPG4 MYOCD CDH13

7.09e-0518910157fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNC ITIH5 NRXN3 CSPG4 MYOCD

7.09e-051891015ab7ece0a517499b70b7754720d3e434765363af6
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LGI4 NRXN3 CSPG4 MYOCD CDH13

7.09e-05189101506b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCellGlobus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

CELF6 KSR2 AAK1 SPTBN4 NRXN3

7.27e-051901015416de85d8841dac883faa6f5339b2fb461a09e82
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEPH MYO15B ACSBG1 CERCAM FGFR3

7.27e-0519010152de8e4cfeee350a9a76af749d6ce58d948c129b8
ToppCell(4)_Endothelial_cells-(40)_EC-arterial|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis

FLNC COL15A1 ITIH5 CDH13 AHNAK2

7.27e-051901015ff774faf3f12759d11e50ed7d189288bb79e22e1
ToppCellASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

COL15A1 LGI4 ITIH5 CSPG4 CDH13

7.45e-051911015e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

COL15A1 NRXN3 CSPG4 MYOCD CDH13

7.45e-05191101504c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCellASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

COL15A1 LGI4 ITIH5 CSPG4 CDH13

7.45e-0519110151726add3f392a061536b7aff72ba84303f4a0b1f
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEPH MYO15B ACSBG1 CERCAM FGFR3

7.45e-051911015f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

LGI4 ITIH5 NRXN3 CSPG4 MYOCD

7.64e-05192101524e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCellControl-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class

AAK1 NOMO1 NOMO2 MPZL2 NOMO3

7.64e-0519210157e89b9125e8b85f6be85eeccef5c8644647ab0e1
ToppCellEntopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32

CELF6 KSR2 AAK1 SPTBN4 NRXN3

7.64e-0519210154c35e5c28a40b439044797ba1f06cb7c36b2a8de
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL15A1 ZYX CSPG4 MYOCD CDH13

7.82e-0519310159a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNC ZYX NRXN3 MYOCD AHNAK2

7.82e-051931015173f1d83133f5ffa88e2a75d28835ad7acd2aa90
ToppCell5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LGI4 TMEM132B ITPK1 NRXN3 P2RX7

7.82e-051931015d5930f7bd9b299f792212d40a3272a37adf64a82
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL15A1 ZYX CSPG4 MYOCD CDH13

7.82e-0519310157c7aa5e2124830d0fa1df11b6413ec6cf780aad0
ToppCell10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FLNC COL15A1 ITIH5 MYH14 CDH13

7.82e-05193101502dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1
ToppCellHippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32

CELF6 KSR2 AAK1 ZWINT SPTBN4

8.02e-0519410158aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LGI4 ITIH5 CSPG4 MYOCD CDH13

8.02e-0519410155c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LGI4 ITIH5 CSPG4 MYOCD CDH13

8.02e-051941015ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RNF149 P2RX7 CD300LB DNAJA1 NCKAP1L

8.02e-051941015dfe0ece81922bfd7c6673726d3ea2365cbdb5513
ToppCellNS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FAM83E SEZ6L2 SLC5A5 MYH14 MPZL2

8.21e-051951015b0d782eeee30c797b4da9b3be29b864983fd9e71
ToppCell15-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class

FLNC COL15A1 ITIH5 CDH13 FRMD3

8.21e-0519510159e9283a397f56732a0a5f2e2527f154d4c2dd56a
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KSR2 AAK1 ANKRD13A MYH14 MPZL2

8.21e-0519510153d6d3de8ada6dce3dc789c15b50cc066e7100496
ToppCell(5)_Fibroblast-K_(Pericytes)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

FLNC LGI4 CSPG4 MYOCD CDH13

8.41e-051961015e3c89c5bd674289738d5590ebfd30c605f5156a5
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLNC LGI4 CSPG4 MYOCD CDH13

8.41e-051961015208ddedd29e1b9ca89cbb9b527c2e193a44cada2
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

AHNAK MKI67 FGFR3 MPZL2 AHNAK2

8.62e-051971015fb272c9c60ee3d980e528044dc567b4925a23da6
ToppCellBronchial_Biopsy-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X

LGI4 ITPK1 MYH14 CSPG4 MYOCD

8.62e-05197101598f0184a09563a544f0c2d4df22c9db2fbc95019
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

AHNAK MKI67 FGFR3 MPZL2 AHNAK2

8.62e-05197101561c0d78b29dc4ad8a84172cbfcdab03f31351d0e
ToppCell5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNC ZYX HEPH NRXN3 MYOCD

8.62e-0519710155a63c2b824c7d0dbbc706e408459c9b9fe65daaa
ToppCellParenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLNC COL15A1 CSPG4 MYOCD CDH13

8.83e-051981015bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FLNC COL15A1 ITIH5 OTOF CDH13

8.83e-05198101555e583321f60c95898d93cd0d2615c6692db52ec
ToppCellBronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FLNC LGI4 CSPG4 MYOCD CDH13

8.83e-051981015705118a5db366b43ffd3389c60e4cb392ad3f2e6
ToppCellTracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FLNC LGI4 NRXN3 CSPG4 MYOCD

8.83e-0519810151e1ea54f0c234f3b6d29064c4881d8a0c0949a75
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KSR2 ITPK1 GREB1L ANKRD13A MPZL2

8.83e-0519810150d9d401190792fd61434f1b82548253187d805f0
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells)

FLNC COL15A1 CSPG4 MYOCD CDH13

8.83e-051981015c82a151f9f1477d4a401457173b8d72af776c137
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells)

FLNC COL15A1 CSPG4 MYOCD CDH13

8.83e-051981015dc63b56bb6291e527b172d603569376286262845
ToppCell10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FLNC COL15A1 ITIH5 OTOF CDH13

9.04e-051991015e19b296d583f8bad3b66ee998a8153634d6fe09e
ToppCellParenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLNC COL15A1 CSPG4 MYOCD CDH13

9.04e-051991015b768496381362f9a2706e0892b5a7a0db82e09ce
ToppCellParenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLNC COL15A1 CSPG4 MYOCD CDH13

9.04e-051991015b1753474152b82a0b811b9878c890a359e14919a
ToppCell10x3'2.3-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FLNC COL15A1 ITIH5 OTOF CDH13

9.04e-051991015801887db51ac5dc5b068808ff75e3a46643398e9
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic

AAK1 NRXN3 OTOF CDH13 FRMD3

9.25e-052001015a9cdddc4e985dae59521e557479c24fcc2ac727d
ToppCellMacroglial|World / cells hierarchy compared to all cells using T-Statistic

HEPH MYO15B ACSBG1 CERCAM FGFR3

9.25e-052001015e6935ad49216d2500c15c05cbc2b89402c65e838
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MYH14 AHNAK FGFR3 MPZL2 AHNAK2

9.25e-05200101597f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCellNeuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic

AAK1 NRXN3 OTOF CDH13 FRMD3

9.25e-05200101533b9199e0dfc267e2cea20b82d1c167f8adcc635
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CACNA1F FAM83E NRXN3 MYH14 CERCAM

9.25e-0520010158683445ad5b70748c4a1f12eb77d47623085147e
ToppCelldistal-3-mesenchymal-Airway_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

FLNC COL15A1 LGI4 MYOCD CDH13

9.25e-0520010154072cfb3047954f507289587b4bfaf1526936992
Diseaseliposarcoma

FRS2 CDK4 CDK6

7.50e-0761003C0023827
Diseaselung adenocarcinoma (is_marker_for)

ABCE1 FUBP1 MKI67 CDK4 CDK6

1.07e-05851005DOID:3910 (is_marker_for)
Diseasenon-functioning pancreatic endocrine tumor (is_marker_for)

CDK4 CDK6

1.14e-0521002DOID:7698 (is_marker_for)
DiseaseMedullary Neoplasms

CDK4 CDK6

6.79e-0541002C0751887
DiseaseBrain Stem Neoplasms, Primary

CDK4 CDK6

6.79e-0541002C0751886
DiseasePontine Tumors

CDK4 CDK6

6.79e-0541002C0751889
DiseaseMesencephalic Neoplasms

CDK4 CDK6

6.79e-0541002C0751888
DiseaseBrain Stem Neoplasms

CDK4 CDK6

6.79e-0541002C0677866
DiseaseChloracne

AHNAK FRMD3 CDK6

1.91e-04331003C0263454
Diseasechemotherapy-induced alopecia, methylcobalamin deficiency type cblE

TRIO CDH13

3.14e-0481002EFO_0005400, MONDO_0009354
Diseasebreast cancer (is_marker_for)

FUBP1 MKI67 FGFR3 CDH13 CDK4

4.27e-041851005DOID:1612 (is_marker_for)
Diseaseurinary bladder cancer (biomarker_via_orthology)

MKI67 CDK4

1.01e-03141002DOID:11054 (biomarker_via_orthology)
DiseaseGlobal developmental delay

INTS1 LGI4 GTF3C3 SLC25A12

1.11e-031331004C0557874
Diseaseamyotrophic lateral sclerosis, age at onset

NRXN3 ARHGEF2

1.16e-03151002EFO_0004847, MONDO_0004976
Diseaseglucose homeostasis measurement, glucose effectiveness measurement

MYH14 CDH13

1.16e-03151002EFO_0006833, EFO_0006896
Diseasepancreatic adenocarcinoma (is_implicated_in)

CDK4 CDK6

1.16e-03151002DOID:4074 (is_implicated_in)
Diseaselipid metabolism disorder (implicated_via_orthology)

LPIN3 HADHA

1.16e-03151002DOID:3146 (implicated_via_orthology)
Diseaseresponse to platinum based chemotherapy

NRXN3 ANKRD7

1.68e-03181002EFO_0004647
DiseaseLiver carcinoma

COL15A1 ZWINT SLC5A5 CSPG4 MKI67 CDH13 CDK4

1.72e-035071007C2239176
Diseasechildhood trauma measurement, alcohol consumption measurement

KSR2 NOMO2 MYOCD

1.83e-03711003EFO_0007878, EFO_0007979
Diseaseprion disease

TBATA POP1

1.87e-03191002EFO_0004720
Diseasesuperior temporal gyrus volume measurement

ITIH5 ANKRD7

1.87e-03191002EFO_0010331
Diseaseurinary bladder cancer (is_implicated_in)

FGFR3 CDH13 CDK4

2.22e-03761003DOID:11054 (is_implicated_in)
DiseaseColorectal Carcinoma

FLNC ZNF232 P2RX7 ABCE1 MKI67 FGFR3 TSKS EXOC4

2.69e-037021008C0009402
Diseasephosphatidylcholine measurement

GREB1L MYO15B LPCAT3 ANKRD7 FRMD3

2.85e-032841005EFO_0010226
Diseasecomparative body size at age 10, self-reported

KSR2 EDEM3 NRXN3 RPTOR ARHGEF2 GCN1

3.11e-034201006EFO_0009819
Diseasebreast carcinoma (is_implicated_in)

CDH13 CDK4

3.24e-03251002DOID:3459 (is_implicated_in)
Diseaseurinary albumin to creatinine ratio

NUMA1 FRS2 WDR81 EDEM3

3.27e-031791004EFO_0007778

Protein segments in the cluster

PeptideGeneStartEntry
PEEGGVEQLQALLPL

C16orf86

226

Q6ZW13
GAPLEGVLVELEVLP

CSPG4

1341

Q6UVK1
PLQVPDAPEKLIEGL

AAK1

781

Q2M2I8
DVQIIDDKGNVLPPG

ACSM2A

391

Q08AH3
KDLLVGPGVELLLTP

ARHGEF2

666

Q92974
GILGSVKPQDPDVLD

FAT4

3631

Q6V0I7
GPDVAVDLPKGDINI

AHNAK

3491

Q09666
LDKPELGPVILEDVL

DOP1A

361

Q5JWR5
DQLGKILDVIGLPGE

CDK6

226

Q00534
NGKTLEGPVPLEVIV

CDH13

221

P55290
EPGLEPGDIIIVLDQ

DNAJA1

231

P31689
GQIPRGLDEQDLKPL

CELF6

51

Q96J87
EIKAEDDQPLPGVLL

NOMO3

881

P69849
LEGVPELLQKILEAP

ANKRD13A

106

Q8IZ07
DLPQENEGLVPGVEK

CACNA1F

781

O60840
PGLLDDPNLVVKING

LPIN3

471

Q9BQK8
EIKAEDDQPLPGVLL

NOMO2

881

Q5JPE7
QIIISAEELPGPKLG

KCNK18

201

Q7Z418
PIEEQGPLDVIIHKL

ITPK1

46

Q13572
LELGPIPAGEEKALE

MAP1S

611

Q66K74
PLLLQVGEGPEAVLT

ITIH5

866

Q86UX2
LLLQEEEPLAGGKPG

INTS1

1586

Q8N201
QLIEEKIGGPVNPLG

FUBP1

441

Q96AE4
GPELPVAGEKNEALV

FYCO1

561

Q9BQS8
LDGGKELKIDIIPNP

HSP90AB4P

41

Q58FF6
IPFEQLEIGELIGKG

KSR2

661

Q6VAB6
PGLQVLKGDIRPAIE

EDEM3

356

Q9BZQ6
KEPGVPGELERQLLQ

MYH14

226

Q7Z406
PPVQIEELIEKPGGI

CRLF3

181

Q8IUI8
VVDGVVIPDDPLVLL

CES4A

321

Q5XG92
EGLLTVQILDPEGKP

FLNC

1571

Q14315
GGELVIPLLVEDPLA

NRXN3

1336

Q9Y4C0
EIKAEDDQPLPGVLL

NOMO1

881

Q15155
LETVLADEPGLLGPK

NCKAP1L

351

P55160
LVQGELIDIPGKIPN

LPCAT3

211

Q6P1A2
KNPPDVDGVIGEIRL

MPZL2

126

O60487
LGEKILPEIIPILEE

GCN1

1956

Q92616
AGDITELKILEIPGP

EDC3

56

Q96F86
VGTPVEKLDLLGNLP

MKI67

1921

P46013
LPCIVILTGKDPLGE

GREB1L

1031

Q9C091
PGPLELVEKNILPVD

MYOCD

116

Q8IZQ8
EKELPPGVEELLNKG

MVP

416

Q14764
AEGPNLIIKQPDELL

REXO2

76

Q9Y3B8
GDLIKLLPVATLEPG

MYO15B

1446

Q96JP2
PILLIQQPGKVTGED

POP1

596

Q99575
PIPGQPEEIQLLRKE

P2RX7

451

Q99572
KGLEEIVPNLEPEGR

CDK3

246

Q00526
PGVEPGDIVLLLQEK

DNAJA2

241

O60884
LKLEGKVPELVGPSE

ERVK-19

161

Q9YNA8
EEELPLGEGVPLPKE

FRMD3

391

A2A2Y4
LGEGVPLPKEENISA

FRMD3

396

A2A2Y4
LIGNLGDKLIPPQDI

EXOC4

686

Q96A65
LKPDEGGEVPVLNVS

ABCE1

396

P61221
DQLGKIFDLIGLPPE

CDK4

221

P11802
QILLEPEGVKFVLGP

FRS2

241

Q8WU20
LKELIITAGGENVPP

ACSBG1

566

Q96GR2
GEPPCLVKLLLQQGV

ANKRD7

201

Q92527
GVELMEPLLEPGQEL

ASAP1

586

Q9ULH1
LDGKIIAVGVIDILP

ATE1

346

O95260
GLVDQLVEPLGPGLK

HADHA

216

P40939
EPVVQGPDGRLELKP

FANCE

71

Q9HB96
PGIPVEELFKLLKEG

FGFR3

696

P22607
VNPEKETAVEGLPGL

CERCAM

451

Q5T4B2
KGEPGAILTEDIPLE

COL15A1

861

P39059
PDVGNGEVPKELVEL

RSF1

56

Q96T23
EDIKLPDGRIIPKGI

CYP4F22

411

Q6NT55
LLNPDKPGIEQGRLE

OTOF

1691

Q9HC10
EELPVQGKLLLLEPE

PRM3

66

Q9NNZ6
PPQEKGEVLGDVLQL

NUMA1

401

Q14980
ILDDLGQPTLEGPEK

FREM3

2086

P0C091
VPVLPKGELEVLLEA

USP9X

86

Q93008
IPLVVIIGEQELKEG

HARS2

461

P49590
PVEGIGQPEKVGLLL

SPRYD4

141

Q8WW59
PIVVAEGEGQGPLIK

TMEM132B

746

Q14DG7
LEAQVKPEPGEPLGV

TCAF2

111

A6NFQ2
GEGQPPLKELVRLEI

FAM83E

136

Q2M2I3
LEPDKGLLEPLQELG

LGI4

481

Q8N135
SPLIEKPGLGQIEEE

NBR1

596

Q14596
LVGPLAICQKGILEP

HEPH

896

Q9BQS7
GPQKELVIPGIVDFE

TBATA

36

Q96M53
VVDGLDELKVPPGAL

NLRP7

251

Q8WX94
EQLLPKEVLSEVGGP

IARS2

571

Q9NSE4
QGLPLKEEEILPEPG

SEZ6L2

26

Q6UXD5
LVPGVTLDLIEKIPG

RPTOR

286

Q8N122
KALELPPLVVEGIEL

GTF3C3

836

Q9Y5Q9
ELQAGQLDVKLPEGP

AHNAK2

1386

Q8IVF2
PDLGTQVKVIVDPEG

CD300LB

111

A8K4G0
GLIPQLIGVAPEKAI

SLC25A12

391

O75746
ILEDLPIQGPKGVDE

SPG11

301

Q96JI7
PKGREILELVQKGIP

RNF149

166

Q8NC42
GILEPVGLQEEAELP

ZWINT

21

O95229
IKEEGPEGPQRIVLQ

TEX13D

516

A0A0J9YY54
LEKLGLPQDQDEPGL

SARG

351

Q9BW04
AILDDNLVKGPEELP

SLC5A5

581

Q92911
IVEQLQEKEAGPGLP

SPTBN4

2326

Q9H254
LEGLGPLKPILEEFG

TSKS

411

Q9UJT2
VVPVLPKGELEVLLE

USP9Y

86

O00507
GAPGPLTLKEVEELE

ZYX

346

Q15942
VLEDLEKGLEPEPQV

ZNF232

126

Q9UNY5
LPLPELEIFQGEGKI

ZNF766

116

Q5HY98
EEEGLPLPLANIKEE

ZNF579

496

Q8NAF0
LAKGLGGLLEVPEQP

WDR81

741

Q562E7
VEEIPPGIVNKELII

TRIO

1326

O75962
VDVLPEGVEPLLVEG

ZAN

2361

Q9Y493